Autolus Therapeutics (AUTL) Receivables - Other (2017 - 2025)
Autolus Therapeutics' Receivables - Other history spans 8 years, with the latest figure at $915000.0 for Q4 2025.
- For Q4 2025, Receivables - Other rose 86.35% year-over-year to $915000.0; the TTM value through Dec 2025 reached $915000.0, up 86.35%, while the annual FY2025 figure was $915000.0, 35.61% down from the prior year.
- Receivables - Other reached $915000.0 in Q4 2025 per AUTL's latest filing, down from $936000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $2.4 million in Q3 2023 to a low of $384000.0 in Q4 2021.
- Average Receivables - Other over 5 years is $867750.0, with a median of $700500.0 recorded in 2024.
- Peak YoY movement for Receivables - Other: soared 273.7% in 2022, then plummeted 74.63% in 2024.
- A 5-year view of Receivables - Other shows it stood at $384000.0 in 2021, then skyrocketed by 273.7% to $1.4 million in 2022, then crashed by 64.04% to $516000.0 in 2023, then fell by 4.84% to $491000.0 in 2024, then soared by 86.35% to $915000.0 in 2025.
- Per Business Quant, the three most recent readings for AUTL's Receivables - Other are $915000.0 (Q4 2025), $936000.0 (Q3 2025), and $665000.0 (Q2 2025).